TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
3 hedge funds and large institutions have $68K invested in TrovaGene, Inc. Warrant in 2017 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
75% less capital invested
Capital invested by funds: $272K → $68K (-$204K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $19K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$241 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $67K | – | – | – |
|
2
Morgan Stanley
New York
| $1K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | +$241 | +954 | +5,612% |
|
TROVW Hedge Fund Activity: Q1 2017 in Review
3 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q1 2017, worth a combined $68K — down 75% from $272K a quarter earlier.
Fund positioning in TROVW was balanced in Q1 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $241.
- 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q1 2017, unchanged from Q4 2016.
- Funds reported $68K of TrovaGene, Inc. Warrant stock for Q1 2017, down 75% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q1 2017 and 0 closed out.
- The largest TrovaGene, Inc. Warrant buyer in Q1 2017 was UBS Group, an estimated $241 added.
Based on aggregated 13F filings for Q1 2017.